Significance: The threat to public health that is presented by zoonotic spillover of pathogens from animal reservoirs is predicted to increase with rapid anthropogenic changes and global trends such as migration and changing land use. Schistosomiasis currently infects more than 220 million people worldwide, and the multihostSchistosomaspp. system within Africa is a key example of where spillover of animal parasites into human populations has enabled the formation of viable hybrid parasite genotypes. Our study demonstrates how zoonotic spillover and complex interactions between pathogen species, such as parasite hybridization, may have implications such as resilience to current disease control strategies and may facilitate the spread of tropical diseases such as schistosomiasis beyond their original geographical boundaries.
Dans ce chapitre, nous étudions le risque pour l’homme ou les animaux domestiques d’être infectés par un agent infectieux (bactérie, parasite ou virus) transmis par les tiques, appelé par la suite « risque de maladies à tiques ». Nous examinons les différentes composantes de ce risque, les facteurs qui l’influencent et comment la modélisation peut permettre de mieux le caractériser et le prédire. Nous nous intéressons principalement aux risques liés aux tiques dures, qui ont pour caractéristique de se poster sur la végétation à l’affût de leur hôte (cf. chap. 2). L’état de nos connaissances sur les tiques molles, le plus souvent endophiles, rend difficile la formalisation mathématique en vue de modéliser la transmission d’agents pathogènes par ces espèces de tiques et donc la modélisation du risque. Le risque pour l’homme ou pour un animal de développer une maladie due à un agent infectieux transmis par les tiques dépend 1) de la probabil...
8 January 2026 in Philosophical Transactions of the Royal Society B: Biological Sciences
While efforts to eliminate schistosomiasis as a public health problem gather momentum, the potential zoonotic risk posed by livestock Schistosoma species via viable hybridization in sub-Saharan Africa has only begun to be appreciated. Recent research revealed widescale use and misuse of praziquantel (PZQ) in livestock among subsistence farmers within West Africa, in response to the often high morbidities and mortalities, and hence socioeconomic impact, of animal schistosomiasis. Such findings raised policy discussion into the potential need to formalize livestock schistosomiasis treatments, balanced against the necessity to protect against PZQ resistance. Here, we present results of an anthelmintic efficacy trial in which 25 mg kg−1 of veterinary-formula PZQ was given orally to naturally Schistosoma spp.-infected domestic ruminants of northern Senegal. Miracidial reduction rates revealed acceptable efficacy levels within cattle infected with S. bovis, but near zero efficacies in goats and sheep infected with S. curassoni and/or hybrids. Furthermore, increased miracidial output post-PZQ was observed among several individuals, particularly within sheep. There was a significant increase in body condition in both cattle and sheep post-PZQ. Microsatellite molecular markers of parasites from bovines indicated a greater level of population genetic differentiation between pre- and post-PZQ samples than between villages, with a genetic signature of inbreeding in one village with the lowest PZQ efficacy. We discuss our findings in terms of their implications and applications towards reaching the WHO elimination targets and the need for future One Health research. This article is part of the Science+ meeting issue ‘Parasite evolution and impact in action: exploring the importance and control of hybrid schistosomes’.